Crescent Capital BDC (CCAP) Stock Price, News & Analysis

Company Overview

Crescent Capital BDC, Inc. is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments. Crescent Capital BDC partners with management teams across a variety of industries—including healthcare, business services, consumer products, and industrials—to support growth initiatives, acquisitions, refinancings, and recapitalizations. By applying a disciplined underwriting process, the firm structures financing packages designed to balance downside protection with the potential for enhanced yields.

Crescent Capital BDC is externally managed by Crescent Capital Group, a credit-focused asset manager founded in 1991. With over three decades of experience in private credit and public debt strategies, Crescent Capital Group leverages deep industry expertise and a collaborative investment approach. Its teams are responsible for sourcing originations, conducting due diligence, structuring transactions, and actively monitoring portfolio companies.

Since its initial public offering in 2017, Crescent Capital BDC has aimed to serve as a reliable source of capital for U.S. middle market businesses. Headquartered in Los Angeles, California, the company’s leadership team comprises seasoned professionals with backgrounds in corporate credit, leveraged finance, and private equity. Through its focus on high-quality middle market opportunities, Crescent Capital BDC seeks to deliver attractive, long-term risk-adjusted returns for its shareholders.

Key Stats

• Today's Range: $11.05 to $11.46
• 50-Day Range: $10.78 to $11.77
• 52-Week Range: $10.64 to $16.03
• Volume: 300,333 shs
• Average Volume: 242,959 shs
• Market Capitalization: $408.30 million
• P/E Ratio: N/A
• Dividend Yield: 12.27%
• Price Target: $13.30
• Consensus Rating: Hold

Crescent Capital BDC Stock Analysis - MarketRank™

Crescent Capital BDC scored higher than 91% of companies evaluated by MarketBeat, and ranked 178th out of 858 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Hold

Consensus Rating

Crescent Capital BDC has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, 4 hold ratings, and no sell ratings.

Upside Potential

Crescent Capital BDC has a consensus price target of $13.30, representing about 20.0% upside from its current price of $11.08.

Amount of Analyst Coverage

Crescent Capital BDC has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 7.97%

Earnings Growth

Earnings for Crescent Capital BDC are expected to grow by 7.97% in the coming year, from $1.38 to $1.49 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Crescent Capital BDC is -123.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Crescent Capital BDC is -123.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Crescent Capital BDC has a P/B Ratio of 0.58. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.52% of the float of Crescent Capital BDC has been sold short.

Short Interest Ratio / Days to Cover

Crescent Capital BDC has a short interest ratio ("days to cover") of 3.56, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Crescent Capital BDC has recently increased by 10.88%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Crescent Capital BDC is a leading dividend payer. It pays a dividend yield of 11.89%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Crescent Capital BDC has only been increasing its dividend for 1 years.

Dividend Sustainability

Based on EPS estimates, Crescent Capital BDC will have a dividend payout ratio of 91.28% in the coming year. This indicates that Crescent Capital BDC may not be able to sustain their current dividend.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.09

News Sentiment

Crescent Capital BDC has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.81 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 18 news articles for Crescent Capital BDC this week, compared to 3 articles on an average week.

Search Interest

Only 2 people have searched for CCAP on MarketBeat in the last 30 days. This is a decrease of -82% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Crescent Capital BDC to their MarketBeat watchlist in the last 30 days. This is a decrease of -83% compared to the previous 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of Crescent Capital BDC in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $107,475.00 in company stock, which represents 0.0263% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Crescent Capital BDC insiders have bought more of their company's stock than they have sold. Specifically, they have bought $107,475.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

1.23% of the stock of Crescent Capital BDC is held by insiders.

Percentage Held by Institutions

49.46% of the stock of Crescent Capital BDC is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Ex-Dividend for 6/15 Dividend: 5/29/2026
• Record date for 6/15 Dividend: 5/31/2026
• Dividend Payable: 6/15/2026
• Last Earnings: 8/10/2026
• Today: 8/12/2026
• Record date for 9/15 Dividend: 8/31/2026
• Ex-Dividend for 9/15 Dividend: 8/31/2026
• Dividend Payable: 9/15/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Capital Markets
• Sub-Industry: Asset Management & Custody Banks
• Current Symbol: NASDAQ:CCAP
• CIK: 1633336
• Web: www.crescentbdc.com
• Phone: 310-235-5900
• Fax: N/A
• Employees: N/A
• Year Founded: 2019

Price Target and Rating

• Average Price Target for Crescent Capital BDC: $13.30
• High Price Target: $16.00
• Low Price Target: $11.00
• Potential Upside/Downside: +20.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.09)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 8.03
• P/E Growth: N/A
• Net Income: $34.51 million
• Net Margins: -2.02%
• Pretax Margin: 41.41%
• Return on Equity: 8.88%
• Return on Assets: 3.82%

Debt

• Debt-to-Equity Ratio: 1.35
• Current Ratio: 1.53
• Quick Ratio: 1.53

Sales & Book Value

• Annual Sales: $167.29 million
• Price / Sales: 2.44
• Cash Flow: $1.66 per share
• Price / Cash Flow: 6.67
• Book Value: $19.09 per share
• Price / Book: 0.58

Miscellaneous

• Outstanding Shares: 36,850,000
• Free Float: 36,393,000
• Market Cap: $408.30 million
• Optionable: Not Optionable
• Beta: 0.52